Protalix BioTherapeutics Inc (PLX) is traded on Tel Aviv Stock Exchange in Israel. It is located in Protalix BioTherapeutics, Inc.Carmiel, and employs 223 people. The company currently falls under 'Small-Cap' category with current market capitalization of 330.36 M. Protalix BioTherapeutics Inc has 0 outstanding shares.
PROTALIX BIOTCS has accumulated about 34.53 M in cash with (27.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.26.
Check Protalix BioTherapeutics Probability Of Bankruptcy